RU94019981A - Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ их получения - Google Patents
Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ их полученияInfo
- Publication number
- RU94019981A RU94019981A RU94019981/04A RU94019981A RU94019981A RU 94019981 A RU94019981 A RU 94019981A RU 94019981/04 A RU94019981/04 A RU 94019981/04A RU 94019981 A RU94019981 A RU 94019981A RU 94019981 A RU94019981 A RU 94019981A
- Authority
- RU
- Russia
- Prior art keywords
- synthesis
- preparing
- pharmaceutical composition
- imidazopyridine derivatives
- imidazopyridine
- Prior art date
Links
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000005862 Angiotensin II Human genes 0.000 claims abstract 2
- 101800000733 Angiotensin-2 Proteins 0.000 claims abstract 2
- 206010020571 Hyperaldosteronism Diseases 0.000 claims abstract 2
- 206010020772 Hypertension Diseases 0.000 claims abstract 2
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 claims abstract 2
- 229950006323 angiotensin ii Drugs 0.000 claims abstract 2
- 230000003042 antagnostic effect Effects 0.000 claims abstract 2
- 230000004410 intraocular pressure Effects 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 206010019280 Heart failures Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4318813.3 | 1993-06-07 | ||
| DE4318813A DE4318813A1 (de) | 1993-06-07 | 1993-06-07 | Imidazopyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU94019981A true RU94019981A (ru) | 1996-06-10 |
Family
ID=6489765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU94019981/04A RU94019981A (ru) | 1993-06-07 | 1994-06-06 | Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ их получения |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5438063A (enExample) |
| EP (1) | EP0628556A1 (enExample) |
| JP (1) | JPH072854A (enExample) |
| KR (1) | KR950000697A (enExample) |
| CN (1) | CN1100721A (enExample) |
| AU (1) | AU689468B2 (enExample) |
| CA (1) | CA2125077A1 (enExample) |
| CZ (1) | CZ137694A3 (enExample) |
| DE (1) | DE4318813A1 (enExample) |
| HU (1) | HUT71483A (enExample) |
| NO (1) | NO942095L (enExample) |
| PL (1) | PL303715A1 (enExample) |
| RU (1) | RU94019981A (enExample) |
| SK (1) | SK67794A3 (enExample) |
| TW (1) | TW269689B (enExample) |
| ZA (1) | ZA943996B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2220723C2 (ru) * | 1996-07-15 | 2004-01-10 | Санкио Компани, Лимитед | Средство и способ лечения или профилактики артериосклероза |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2708612B1 (fr) * | 1993-08-05 | 1996-03-01 | Roussel Uclaf | Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant. |
| DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
| DE19845153A1 (de) * | 1998-10-01 | 2000-04-06 | Merck Patent Gmbh | Imidazo[4,5]-pyridin-4-on-derivate |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| US7074810B2 (en) | 2002-10-07 | 2006-07-11 | Bristol-Myers Squibb Company | Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| DK2161273T3 (en) | 2003-12-22 | 2015-07-20 | Leuven K U Res & Dev | Imidazo [4,5-C] pyridine compounds and methods for antiviral therapy |
| PT1841765E (pt) | 2004-12-21 | 2009-05-14 | Gilead Sciences Inc | Anticorpos para mcp-1 humano |
| AR055755A1 (es) * | 2005-03-30 | 2007-09-05 | Takeda Pharmaceutical | Derivado de bencimidazol, procesos de obtencion, composiciones farmaceuticas y usos. |
| US7754720B2 (en) | 2006-07-07 | 2010-07-13 | Gilead Sciences, Inc. | Pyridazine compound and use thereof |
| UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
| JP2011526881A (ja) * | 2008-06-25 | 2011-10-20 | ファイザー・インク | ジアリール化合物およびそれらの使用 |
| WO2009158309A2 (en) * | 2008-06-25 | 2009-12-30 | Ligand Pharmaceuticals Inc. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| CN102037000A (zh) | 2008-07-08 | 2011-04-27 | 株式会社钟化 | α-杂取代烷基卤代氢硅烷的制造方法及其应用 |
| CZ306650B6 (cs) * | 2011-03-04 | 2017-04-19 | Zentiva, K.S. | Způsob výroby 2-ethoxy-1-((2´-((hydroxyamino)iminomethyl)bifenyl-4-yl)methyl)-1H-benzo[d]imidazol-7-karboxylové kyseliny a jejích esterů, klíčových intermediátů syntézy azilsartanu |
| WO2015095108A1 (en) * | 2013-12-18 | 2015-06-25 | Merck Sharp & Dohme Corp. | Thioether-piperidinyl orexin receptor antagonists |
| CN105669495A (zh) * | 2014-11-21 | 2016-06-15 | 重庆朗天制药有限公司 | 一种阿奇沙坦及其中间体新的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
| US5332744A (en) * | 1989-05-30 | 1994-07-26 | Merck & Co., Inc. | Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists |
| US5223499A (en) * | 1989-05-30 | 1993-06-29 | Merck & Co., Inc. | 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists |
| EP0430709A3 (en) * | 1989-12-01 | 1992-02-12 | Glaxo Group Limited | Benzthiophen derivatives |
| DE4110019C2 (de) * | 1991-03-27 | 2000-04-13 | Merck Patent Gmbh | Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
| IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them |
| DE4141788A1 (de) * | 1991-12-18 | 1993-06-24 | Merck Patent Gmbh | Imidazopyridine |
| DE4305602A1 (de) * | 1992-06-17 | 1993-12-23 | Merck Patent Gmbh | Imidazopyridine |
-
1993
- 1993-06-07 DE DE4318813A patent/DE4318813A1/de not_active Withdrawn
-
1994
- 1994-05-30 EP EP94108296A patent/EP0628556A1/de not_active Withdrawn
- 1994-06-01 AU AU63487/94A patent/AU689468B2/en not_active Expired - Fee Related
- 1994-06-03 CA CA002125077A patent/CA2125077A1/en not_active Abandoned
- 1994-06-03 SK SK677-94A patent/SK67794A3/sk unknown
- 1994-06-03 TW TW083105084A patent/TW269689B/zh active
- 1994-06-04 KR KR1019940012630A patent/KR950000697A/ko not_active Withdrawn
- 1994-06-04 CN CN94106500A patent/CN1100721A/zh active Pending
- 1994-06-06 RU RU94019981/04A patent/RU94019981A/ru unknown
- 1994-06-06 HU HU9401692A patent/HUT71483A/hu unknown
- 1994-06-06 NO NO942095A patent/NO942095L/no unknown
- 1994-06-06 PL PL94303715A patent/PL303715A1/xx unknown
- 1994-06-06 CZ CZ941376A patent/CZ137694A3/cs unknown
- 1994-06-06 US US08/254,834 patent/US5438063A/en not_active Expired - Fee Related
- 1994-06-07 JP JP6125330A patent/JPH072854A/ja active Pending
- 1994-06-07 ZA ZA943996A patent/ZA943996B/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2220723C2 (ru) * | 1996-07-15 | 2004-01-10 | Санкио Компани, Лимитед | Средство и способ лечения или профилактики артериосклероза |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2125077A1 (en) | 1994-12-08 |
| HU9401692D0 (en) | 1994-09-28 |
| HUT71483A (en) | 1995-11-28 |
| CN1100721A (zh) | 1995-03-29 |
| CZ137694A3 (en) | 1994-12-15 |
| US5438063A (en) | 1995-08-01 |
| AU6348794A (en) | 1994-12-08 |
| AU689468B2 (en) | 1998-04-02 |
| TW269689B (enExample) | 1996-02-01 |
| NO942095L (no) | 1994-12-08 |
| SK67794A3 (en) | 1995-02-08 |
| JPH072854A (ja) | 1995-01-06 |
| KR950000697A (ko) | 1995-01-03 |
| PL303715A1 (en) | 1995-01-09 |
| EP0628556A1 (de) | 1994-12-14 |
| DE4318813A1 (de) | 1994-12-08 |
| ZA943996B (en) | 1995-02-06 |
| NO942095D0 (no) | 1994-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94042907A (ru) | Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения | |
| RU94041198A (ru) | Производные имидазопиридазина, способ их получения, содержащая их фармацевтическая композиция, способ ее получения | |
| MX9307940A (es) | Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen | |
| YU69991A (sh) | Derivati piridina | |
| GEP20022678B (en) | Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment | |
| RU94039542A (ru) | Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция | |
| MX9604378A (es) | Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios. | |
| NL300006I1 (nl) | Imidazolylalkeenzuurderivaten. | |
| ATE235459T1 (de) | Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren | |
| GEP20033114B (en) | Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists, Method for Their Production and Pharmaceutical Compositions Containing the Same | |
| CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
| TNSN95117A1 (fr) | Les acides substitues 4-biarylbutyrique ou 5-biarylpentanoique et derives en tant qu'inhibiteurs de metallprotease matricielle | |
| GEP20043237B (en) | Pyrazoline Derivatives, Method for Their Preparation and Compositions Containing Them for Treatment of Diseases Mediated by Cyclooxygenase-2 | |
| RU94046067A (ru) | Замещенные 1,2,3,4-тетрагидроизохинолины, промежуточные продукты, фармкомпозиция и способ лечения | |
| RU94027573A (ru) | Замещенные пиразолилпиразолы и способ их получения | |
| RU94046411A (ru) | Производные витамина д, способ их получения, фармацевтическая композиция на их основе и способ ее получения, способ лечения | |
| ATE223912T1 (de) | Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel | |
| HU907025D0 (en) | Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance | |
| RU94040914A (ru) | Производные индола как вещества, обладающие сродством к рецептору 5-нтi, фармкомпозиция и способ лечения | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| TNSN87012A1 (fr) | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques | |
| RU94038256A (ru) | Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе | |
| EA200000996A1 (ru) | Конденсированные с арилом азаполициклические соединения | |
| RU94039284A (ru) | Производные пиперазина, способ их получения, фармкомпозиция и ее использование | |
| IT1256320B (it) | Derivati eterociclici |